Supporting Reproductive Health and Fertility

Caromax D-chiro-inositol

D-Chiro-inositol improves impaired fertility associated to age or polycystic ovary syndrome.

A natural solution devoid of the unwanted side effects of hormonal replacement or artificial reproductive technologies

Efficient

Improves fertility without unwanted side effect

Antioxidant

Derived from a natural source

Bioavailable

Easily absorbed and utilized by the body

Cost-effective

Affordable solution for enhancing fertility

PropERTIES

  • Improves fertility in late reproductive-age women
  • Reduces PCOS-associated infertility
  • Reduces PCOS-associated insulin resistance and androgenism
  • Weight control in obesity

Health areaS

Women´s Health

Weight Control

Cognitive and mood support

Bone Health

Diabetes

ideal for

A natural inositol promoting fertility

Infertility its growing concern in our society. Search for pregnacy in late reproductive ages, the presence of factors and diseases reducing women’s fertility, limits the possibility of a succesful reproduction. Options available are limited and expensive.

Fertility without a personal cost

D-Chiro-inositol enhances fertility by improving the mechanisms related with ovulation, increasing sex-steroid production, decreasing insulin resistance and normalizing lipid metabolic imbalances. All these synergies occurring without known side-effects and at an affordable cost for all users. caromax d-chiro-inositol active ingredient (DCI) has been demonstrated to improve/restore ovulation in women suffering PCOS, reversing infertility in a relevant percentage. caromax d-chiro-inositol is the only natural pure DCI available for human treatment, in comparison with other synthetic non natural/ecological products.


RESEARCH

[1] D-Chiro-Inositol Treatment Affects Oocyte and Embryo Quality and Improves Glucose Intolerance in Both Aged Mice and Mouse Models of Polycystic Ovarian Syndrome     Pericuesta E, Laguna-Barraza R, Ramos-Ibeas P, Gutierrez-Arroyo JL, Navarro JA, Vera K, Sanjuan C, Baixeras E, de Fonseca FR, Gutierrez-Adan A. Int J Mol Sci. 2020 Aug 22;21(17):6049.


Disclaimer:

The information presented in this page is intended to provide general information on our premium products, their properties and potential applications. It is based on our present state of knowledge and must not be construed as guaranteeing specific properties or approvals of the products described herein or their suitability for any application described. The user is solely responsible for compliance with the existing approvals in the county of use. It is also the sole responsibility of the user to investigate whether existing patents are infringed by the use of the materials described herein. Adequate quality of our products is guaranteed under our General Conditions of Sales. All statements in this page have not been evaluated by the US Food and Drug Administration or EFSA. This product is not intended to diagnose, treat, cure, or prevent any disease.

news

VITAFOODS 2020, the global nutraceutical industry returns to Geneva on 12-14 May 2020. Over the past 22 years Vitafoods Europe...
The INNOVATIVE SME seal recognizes the innovative nature of Euronutra and its participation in numerous projects of public calls for...
A new year has started according to Chinese calendar. It is the Year of the Dog! Euronutra doesn’t want to...